[1] |
GUIDO M, SARCOGNATO S, SACCHI D, et al. Pathology of idiopathic non-cirrhotic portal hypertension[J]. Virchows Arch, 2018, 473(1): 23-31. DOI: 10.1007/s00428-018-2355-8.
|
[2] |
Working Subgroup for Clinical Practice Guideline for Aberrant Portal Hemodynamics. Diagnosis and treatment guidelines for aberrant portal hemodynamics: The Aberrant Portal Hemodynamics Study Group supported by the Ministry of Health, Labor and Welfare of Japan[J]. Hepatol Res, 2017, 47(5): 373-386. DOI: 10.1111/hepr.12862.
|
[3] |
SARIN SK. Non-cirrhotic portal hypertension[M]//Advances in Therapeutic Hepatology: A World View. Chicago: IASL, 1998: 111-124.
|
[4] |
ZHANG Y, TANG SH, MOU D, et al. A case of idiopathic portal hypertension[J]. J Clin Hepatol, 2017, 33(4): 738-739. DOI: 10.3969/j.issn.1001-5256.2017.04.031.
|
[5] |
ZHU Q, XIANG CH. Current status regarding diagnosis and management of idiopathic portal hypertension[J]. Chin J Gen Surg, 2019, 28(1): 117-124. DOI: 10.7659/j.issn.1005-6947.2019.01.016.
朱青, 项灿宏. 特发性门静脉高压症的诊治现状[J]. 中国普通外科杂志, 2019, 28(1): 117-124. DOI: 10.7659/j.issn.1005-6947.2019.01.016.
|
[6] |
HERNÁNDEZ-GEA V, BAIGES A, TURON F, et al. Idiopathic portal hypertension[J]. Hepatology, 2018, 68(6): 2413-2423. DOI: 10.1002/hep.30132.
|
[7] |
GÓMEZ ALONSO M, GOÑI ESARTE S, BOLADO CONCEJO F, et al. Idiopathic non-cirrhotic portal hypertension and portal vein thrombosis in a patient with HIV infection[J]. Gastroenterol Hepatol, 2017, 40(5): 353-354. DOI: 10.1016/j.gastrohep.2016.03.005.
|
[8] |
POLA S, BOLAND BS, LIN GY, et al. Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease[J]. Dig Dis Sci, 2014, 59(7): 1642-1644. DOI: 10.1007/s10620-014-3052-3.
|
[9] |
KOOT BG, ALDERS M, VERHEIJ J, et al. A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension[J]. J Hepatol, 2016, 64(4): 974-977. DOI: 10.1016/j.jhep.2015.11.027.
|
[10] |
CAI MX, LIN LW, XUE ES, et al. Color Doppler in the diagnosis of idiopathic portal hypertension and its clinical value[J]. J Clin Hepatol, 2009, 25(5): 374-376. http://lcgdbzz.org/article/id/LCGD200905023
蔡敏娴, 林礼务, 薛恩生, 等. 特发性门静脉高压症的彩色多普勒超声诊断与临床价值[J]. 临床肝胆病杂志, 2009, 25(5): 374-376. http://lcgdbzz.org/article/id/LCGD200905023
|
[11] |
SHARMA P, AGARWAL R, DHAWAN S, et al. Transient elastography (fibroscan) in patients with non-cirrhotic portal fibrosis[J]. J Clin Exp Hepatol, 2017, 7(3): 230-234. DOI: 10.1016/j.jceh.2017.03.002.
|
[12] |
LIU X, WANG TL, XIANG CH, et al. Liver pathology in idiopathic portal hypertension[J]. Chin J Hepatol, 2007, 15(5): 374-377. DOI: 10.3760/j.issn:1007-3418.2007.05.015.
刘霞, 王泰龄, 项灿宏, 等. 特发性门静脉高压的肝脏病理学分析[J]. 中华肝脏病杂志, 2007, 15(5): 374-377. DOI: 10.3760/j.issn:1007-3418.2007.05.015.
|
[13] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver[J]. J Hepatol, 2016, 64(1): 179-202. DOI: 10.1016/j.jhep.2015.07.040.
|
[14] |
XU HF, DING HG. Diagnosis and treatment of pre-hepatic (sinusoidal) non-cirrhotic portal hypertension and related difficulties[J]. J Clin Hepatol, 2019, 35(1): 13-17. DOI: 10.3969/j.issn.1001-5256.2019.01.002.
徐航飞, 丁惠国. 肝(窦)前型非肝硬化门静脉高压症的诊断与治疗及其面临的困境[J]. 临床肝胆病杂志, 2019, 35(1): 13-17. DOI: 10.3969/j.issn.1001-5256.2019.01.002.
|